triazoles has been researched along with Arthritis, Spinal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraliakos, X; Barchuk, W; Besuyen, R; Gilles, L; Hendrikx, T; Landewé, R; Liu, K; Maksymowych, WP; Østergaard, M | 1 |
| Baraliakos, X; Barchuk, W; Besuyen, R; Gilles, L; Hendrikx, T; Landewé, R; Liu, K; Maksymowych, WP; Tasset, C; Østergaard, M | 1 |
1 trial(s) available for triazoles and Arthritis, Spinal
| Article | Year |
|---|---|
Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).
Topics: Adult; Humans; Janus Kinase Inhibitors; Magnetic Resonance Imaging; Metaplasia; Pyridines; Sacroiliac Joint; Spondylarthritis; Spondylitis, Ankylosing; Triazoles | 2022 |
1 other study(ies) available for triazoles and Arthritis, Spinal
| Article | Year |
|---|---|
Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial.
Topics: Humans; Inflammation; Magnetic Resonance Imaging; Pyridines; Severity of Illness Index; Spine; Spondylarthritis; Spondylitis, Ankylosing; Triazoles; Vertebral Body; Zygapophyseal Joint | 2022 |